Seed Intellectual Property Law Group PLLC

BACKGROUND

Dave Enfield specializes in patent matters pertaining to biotechnology and medical devices. He received a B.S. in Life Sciences from Massachusetts Institute of Technology (1966) and a Ph.D. in Medical Physiology from Boston University (1972). His graduate research related to muscle chemistry and physiology. After receiving his Ph.D., he held postdoctoral research positions at the University of Washington, where he studied the protein chemistry of blood coagulation and automated methods for amino acid sequence determination.

EXPERIENCE

Following his academic research experience, Dave held several research and product development positions in the animal pharmaceutical and human medical device and diagnostics industries. These included IMC Pittman Moore, Sanofi, Biotope, and the Bard Diagnostic Sciences subsidiary of C.R. Bard. He has co-authored a number of scientific articles, is an inventor on issued patents, and has successfully brought projects through FDA approval and market release.

Dave served as the Patent Officer at Bard Diagnostic Sciences and, prior to joining Seed IP, was a corporate Patent Agent at NeoRx Corporation, involved in the prosecution and management of an extensive portfolio of biotechnology and chemistry patents and applications.

AFFILIATIONS

Dave is registered to practice before the U.S. Patent and Trademark Office. His professional affiliations include the Washington State Patent Law Association, American Intellectual Property Law Association, and the Washington Biotechnology and Biomedical Association.